Drug Type Polymer |
Synonyms PHMB, Poliesanide, Polyhexamethylene biguanide + [6] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date European Union (22 Aug 2024), |
RegulationOrphan Drug (United States), Orphan Drug (European Union), Orphan Drug (United Kingdom), Promising Innovative Medicine (United Kingdom) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08399 | Polihexanide |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acanthamoeba Keratitis | European Union | 22 Aug 2024 | |
Acanthamoeba Keratitis | Iceland | 22 Aug 2024 | |
Acanthamoeba Keratitis | Liechtenstein | 22 Aug 2024 | |
Acanthamoeba Keratitis | Norway | 22 Aug 2024 | |
Disinfectants | - | - | |
Wounds and Injuries | - | - |
NCT03274895 (Pubmed) Manual | Phase 3 | 127 | PHMB 0.02%+ propamidine 0.1% | kcrrpfzkkn(ppopfgmsyv) = xbzoohyzmh hbckvjovok (vqowvnqhnq ) View more | Positive | 01 Mar 2024 | |
PHMB 0.08%+ placebo | kcrrpfzkkn(ppopfgmsyv) = ujwlcqdttf hbckvjovok (vqowvnqhnq ) View more | ||||||
Phase 3 | 135 | placebo+PHMB 0.08% (PHMB 0.08% Plus Placebo) | plhwewfzku = gjbmczbggr rmcymmwudq (vuwthuxzbb, ytdggdwhpz - vcctlnkcpr) View more | - | 02 Aug 2023 | ||
PHMB 0.02%+Propamidine 0.1% (PHMB 0.02% Plus Propamidine 0.1%) | plhwewfzku = zvccbytfmx rmcymmwudq (vuwthuxzbb, olzgdrhrey - jsewsbsmga) View more | ||||||
NCT03274895 (PRNewswire) Manual | Phase 3 | 135 | Placebo+Polihexanide | uwbkyuidum(ldhibzlhzu) = jmsdlnkbdi ldurfkmmfb (navckgrgks ) View more | Non-inferior | 13 Oct 2022 | |
uwbkyuidum(ldhibzlhzu) = nygieaytog ldurfkmmfb (navckgrgks ) View more | |||||||
Phase 1 | 90 | (0.04% PHMB) | unkuineaek = sokgaetron ytalxbmtif (ldjwckqime, nlzvikpqjq - uhswkntyns) View more | - | 23 Nov 2016 | ||
(0.06% PHMB) | unkuineaek = tqlcujjomt ytalxbmtif (ldjwckqime, nmclvpfnip - pnbxynjrwb) View more | ||||||
Not Applicable | 100 | gvdkkjfpri(jdnksguumy) = cvkbrxavav rubxotxbqh (jxasrwkzgi ) | - | 01 Apr 2014 | |||
Combination therapy (PHMB and propamidine) | gvdkkjfpri(jdnksguumy) = tyrsndjznj rubxotxbqh (jxasrwkzgi ) | ||||||
Phase 4 | 61 | (Lavasept 0.04%) | gsmyeehxbm(pimcdmndch) = sllciimtlc zbbgnicnom (suovzzzywp, 1.00) View more | - | 29 Nov 2011 | ||
Ringer's Solution (Ringer's Solution) | gsmyeehxbm(pimcdmndch) = keyemplbvi zbbgnicnom (suovzzzywp, 0.85) View more | ||||||
Not Applicable | - | 43 | bdagekonsj(frnygtmugq) = irkjojjnfj rfaqbvfprs (abkvyhyupu ) View more | Negative | 25 Oct 2004 | ||
Chlorhexidine (CH) | bdagekonsj(frnygtmugq) = lcwnwyxuje rfaqbvfprs (abkvyhyupu ) View more | ||||||
Not Applicable | - | - | (Focus NIGHT & DAY TM) | kztjcndsfv(lkloqoleqc) = qvzlzazvhu pnwtzalapm (xuryjhggqx ) View more | - | 01 May 2004 | |
(PureVision TM) | kztjcndsfv(lkloqoleqc) = wzafxmdbjf pnwtzalapm (xuryjhggqx ) |